R-Roseburg

House May Roll Back Bill Expanding Drug Monitoring Program

The Lund Report
Rep. Mitch Greenlick opposes allowing the Board of Pharmacy to add drugs to the tracking system that are not controlled by the DEA, aligning his concerns with the American Civil Liberties Union.

Editor's Note: This article has been amended for accuracy.

May 9, 2013 — Rep. Mitch Greenlick, D-Portland, has moved to scale back a measure that would enhance the Oregon Prescription Drug Monitoring Program, citing concerns raised by the American Civil Liberties Union.

Subscribe to R-Roseburg